Wingspan Adds eREG Solution to Life Sciences Platform
Debuts Solution for Regulatory Submission Management
PHILADELPHIA, PA. - Wingspan Technology, the leading provider of content management solutions for life sciences, announced the release of Wingspan eREG, the newest edition to their Life Sciences Solution. Wingspan eREG is a cloud-based software solution for managing documents included in regulatory submissions and related documents. Wingspan eREG is built on the same user-friendly platform as Wingspan eTMF, providing intuitive user dashboards to provide transparency, insight, and accountability into the status of documents needed for upcoming submissions. Wingspan eREG provides streamlined processes for creation and approval of submission content, re-use of non-product specific documents such as excipients in multiple products, and support for submission assembly and publishing, including submission-ready PDFs. “We are happy to add Wingspan eREG to our complete, consistent, compliant platform for life sciences,” said Troy Deck, CEO of Wingspan Technology. “By applying the industry-leading technology of Wingspan eTMF to regulatory documentation, we are able to provide our customers with an easy way to manage and execute on the highly detailed regulatory process.” Wingspan will host a live demonstration of the new product in its “
Introducing Wingspan eREG
” webinar on July 26. In addition to Wingspan eREG, the Wingspan Life Sciences Solution also includes other cloud-based solutions – Wingspan eTMF and SiteZone, a site document exchange, offering customers a complete and integrated platform to drive efficiencies into the drug or device development process.
About Wingspan Technology, Inc.
Wingspan Technology, Inc. is the leading provider of life sciences and eClinical software solutions, including Wingspan eTMF and DocWay, the SharePoint/Documentum integration product suite. Wingspan's talented and knowledgeable engineering and project management teams offer in-depth industry knowledge and experience to companies in life sciences, pharmaceutical, financial services, and other fields.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Merck Launches Phase III Trials of Once-Monthly Oral HIV PrEP Candidate MK-8527
July 14th 2025In the new EXPrESSIVE clinical trial program, Merck will evaluate MK-8527, a once-monthly, oral PrEP therapy, in populations at high risk of HIV-1 infection, including adolescent girls and women in sub-Saharan Africa.
Baxdrostat Shows Significant Blood Pressure Reduction in Phase III BaxHTN Trial
July 14th 2025In the BaxHTN Phase III study, AstraZeneca’s baxdrostat demonstrated statistically significant and clinically meaningful reductions in systolic blood pressure in patients with uncontrolled or treatment-resistant hypertension.
